Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024)
Oruka Therapeutics (ORKA) recorded quarterly Interest & Investment Income of $444000.0 in Q2 2024, down 6.13% quarter-over-quarter from $473000.0 in Q1 2024, and down 9.94% on a YoY basis from $493000.0 in Q3 2023.
Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Interest & Investment Income history runs 15 years deep, the most recent figure standing at $444000.0 for Q2 2024.
- In Q2 2024, Interest & Investment Income fell 9.94% year-over-year to $444000.0; the TTM figure through Jun 2024 stood at $1.9 million (up 25.47% YoY), while the FY2023 annual figure was $2.0 million, up 189.93% from the prior year.
- Interest & Investment Income was $444000.0 for Q2 2024 at Oruka Therapeutics, down from $473000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $513000.0 in Q3 2023 to a low of $1000.0 in Q3 2020.
- Historically, Interest & Investment Income has averaged $199444.4 across 5 years, with a median of $48000.0 in 2020.
- The sharpest annual moves came in 2020 and 2022: Interest & Investment Income tumbled 98.0% in 2020, then jumped 9250.0% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $1000.0 in 2020, then surged by 300.0% to $4000.0 in 2021, then surged by 9250.0% to $374000.0 in 2022, then surged by 33.96% to $501000.0 in 2023, then slipped by 11.38% to $444000.0 in 2024.
- The last three Interest & Investment Income figures came in at $444000.0 (Q2 2024), $473000.0 (Q1 2024), and $501000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | Oruka Therapeutics | 3.54 Bn | 3.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 444,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 513,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Jun 30, 2022 | 72,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | 24,000.00 |
| Dec 31, 2019 | 36,000.00 |
| Sep 30, 2019 | 50,000.00 |